Roivant Sciences Ltd. SEC filings ROIV
Roivant Sciences Ltd. has 997 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 18, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Results of operations
|
May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 2, 2026 | Apr 2, 2026 |
| 8-K/A |
Amended current report
Material agreement
|
Mar 23, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 11, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Results of operations
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2025 | Mar 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 3, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Oct 28, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement
|
May 30, 2024 | May 24, 2024 |
| 8-K |
Current report
Results of operations
|
May 30, 2024 | May 30, 2024 |
| 8-K |
Current report
Other events
|
Apr 2, 2024 | Apr 2, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K/A | Amended current report | Dec 20, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Other events
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 23, 2023 | Oct 22, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 29, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 15, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Other events
|
Aug 17, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 4, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Other events
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Jun 28, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Results of operations
|
Jun 28, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Other events
|
Jun 22, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Other events
|
May 16, 2023 | May 16, 2023 |
| 8-K |
Current report
Other events
|
Apr 4, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2023 | Feb 20, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 7, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Other events
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2022 | Dec 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 23, 2022 | Nov 17, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Agreement ended, Officer or director change, Shareholder vote results
|
Sep 21, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jun 28, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Feb 14, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
|
Oct 1, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Other events
|
Sep 28, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 21, 2021 | Sep 21, 2021 |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ROIV (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Bermuda
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1635088
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.